Bavarian Nordic Wins Up-to-$539M BARDA Contract for Smallpox Vaccine

Bavarian Nordic has won an up-to-$539 million contract from the Biomedical Advanced Research and Development Authority (BARDA) to supply its freeze-dried Imvamune ® smallpox vaccine for the U.S. Strategic National Stockpile.The contract consists of an initial $100 million base award toward manufacturing and storage of Imvamune vaccine bulk—the third bulk contract inked between the company and BARDA. The two earlier bulk contracts total a combined $233 million.“We are proud to be